Analysis of Two Neuroanatomical Subtypes of Parkinson's Disease and Their Motor Progression Based on Semi‐Supervised Machine Learning
CNS Neuroscience & Therapeutics · 2025
DOI: 10.1111/cns.70277 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2025. Verfasst von Hao Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Parkinson Disease, Supervised Machine Learning, Brain. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Jiangsu Province Traditional Chinese Medicine Science and Technology Development Plan Project, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Background
The high heterogeneity of Parkinson's disease (PD) hinders personalized interventions. Brain structure reflects damage and neuroplasticity and is one of the biological bases of symptomatology. Subtyping PD in the framework of brain structure helps in the prediction of disease trajectories and optimizes treatment strategies.
Methods
The study included a total of 283 de novo PD and 141 healthy controls (HC). Structural heterogeneity between PD and HC was compared, and patients were classified using Heterogeneity through Discriminative Analysis. Gray matter volume (GMV), clinical symptoms, and substantia nigra free water (SNFW) among all subtypes were compared. These subtypes were followed for an average of 2.5 years to monitor motor impairment.
Results
Early PD patients possessed higher GMV heterogeneity than HC, and two subtypes based on GMV patterns were identified. Subtype 1 showed widespread GMV reductions, while subtype 2 had an increased volume in the basal ganglia and parts of the cortex. Subtype 1 had more severe motor and non‐motor symptoms, as well as higher posterior SNFW. The whole‐brain GMV in the PD group was negatively correlated with posterior SNFW; basal ganglia volume in subtype 1 was negatively correlated with Unified Parkinson's Disease Rating Scale (UPDRS)‐III scores, whereas no linear correlation was found in subtype 2. The UPDRS‐III progression rate was higher in subtype 1 than in subtype 2 (2.52 vs 0.92 points/year).
Conclusion
The heterogeneity of PD patients reflected the changes in their brain structure. The identification of these changes helps the classification of patients into different subtypes, additionally supported by clinical manifestations and SNFW, with consequent benefits for clinical consultancy and precision medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing, China.
ORCID-Profile: Hao Zhou, Yi Xing, Jingru Ren, Weiguo Liu
Förderung
- National Natural Science Foundation of China
- Jiangsu Province Traditional Chinese Medicine Science and Technology Development Plan Project
- Natural Science Foundation of Jiangsu Province
- Key Project of Jiangsu Provincial Health Commission
Zitieren
APA
Zhou, H., Wu, Y., Chen, S., Xing, Y., Ren, J., & Liu, W. (2025). Analysis of Two Neuroanatomical Subtypes of Parkinson's Disease and Their Motor Progression Based on Semi‐Supervised Machine Learning. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70277
Vancouver
Zhou H, Wu Y, Chen S, Xing Y, Ren J, Liu W. Analysis of Two Neuroanatomical Subtypes of Parkinson's Disease and Their Motor Progression Based on Semi‐Supervised Machine Learning. CNS Neuroscience & Therapeutics. 2025. doi:10.1111/cns.70277
BibTeX
@article{Zhou2025,
author = {Zhou, Hao and Wu, Yuqing and Chen, Shuoying and Xing, Yi and Ren, Jingru and Liu, Weiguo},
title = {Analysis of Two Neuroanatomical Subtypes of Parkinson's Disease and Their Motor Progression Based on Semi‐Supervised Machine Learning},
journal = {CNS Neuroscience & Therapeutics},
year = {2025},
doi = {10.1111/cns.70277}
}
EUVIMED